Gene therapy for the treatment of heart failure: promise postponed - Wikidata - awgldk - TriplyDB

Gene therapy for the treatment of heart failure: promise postponed

Gene therapy for the treatment of heart failure: promise postponed

http://www.wikidata.org/entity/Q36953151

about

Cardiovascular Gene Therapy: Past, Present, and Future.Current Methods in Cardiac Gene Therapy: Overview.Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy.Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease.Sex Differences in Metabolic Cardiomyopathy.Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy.Recent Advances in Understanding and Managing Cardiomyopathy.Introducing Genes to the Heart: All About Delivery.Modified mRNAs in the Cardiovascular System: A New Platform for Gene Therapy.MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target.SERCA control of cell death and survival.Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology

P2860

Q38733395-9AC44986-8620-4377-9FED-B878AEDDA59B Q38788217-2B0A7979-F9B0-45B6-92A9-566A74DF3DB8 Q38788545-8FAB4436-4820-4715-8637-82813AE494F4 Q38844989-F07AA4A4-98EC-4A0F-B913-75FC43E86DCA Q39027005-858A25F4-70D3-4FD5-AB81-39ACB3B8EB8D Q39118050-83343096-799F-4C61-9511-5161D2E03027 Q41526246-D971B0C1-7643-49F7-BC3B-7080A59D26BB Q41528372-04B1CD89-6435-4516-AC9B-5ADEC707041C Q45863402-CAF0A0B4-5978-4A31-86E1-9CFA6A6C97E0 Q45868301-E1BBD039-EBC7-4035-9026-536B756ED39A Q45875338-143EFF23-EF17-4395-804C-B37D5EF7BF63 Q46330392-83E81160-E5CA-4E57-8FC2-D5EFF96BAA11 Q51041886-646A5E09-E34F-4250-9001-B5E19289006D Q52604700-D36E47E2-90BA-4171-9FF6-CC52D92D31EA Q57162894-9507E306-10D2-47AF-BA29-575674299E6C

P2860

Gene therapy for the treatment of heart failure: promise postponed

http://www.wikidata.org/entity/Q36953151

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Gene therapy for the treatment of heart failure: promise postponed

@en

type

label

Gene therapy for the treatment of heart failure: promise postponed

@en

prefLabel

Gene therapy for the treatment of heart failure: promise postponed

@en

P1433

Q36953151-1C23D619-676E-4D1B-8CFB-D387E3F8813A

P1476

Q36953151-C01C5624-1567-4661-A15D-4CD2AC717966

P2093

Q36953151-04585763-D840-4BDA-A7D5-3E1C54A94EDB

Q36953151-86C6D079-AE08-4F23-8A18-CA384D774314

P2860

Q36953151-094BDEC8-CFF6-409D-980F-1ED199BD68E1

Q36953151-165EFF27-D197-4722-9489-5479599877A6

Q36953151-1E39E7A7-E724-49E4-9446-041FEE2AF8B5

Q36953151-1EAD8773-23F3-4BE4-826E-D7DAAC84698F

Q36953151-265BF2CA-5377-4767-9DB7-035F86548E12

Q36953151-2AD5A44F-E8D8-4804-A040-7A75722102E8

Q36953151-3C52BB9B-79A9-449B-8CD3-141066569EB4

Q36953151-4BE85E5E-98C0-4E8B-8416-E9F13D03351B

Q36953151-4C53B555-105A-42CB-8F26-2E69B3C14701

Q36953151-555E25D1-9BC1-42FA-AD84-FFA2AFBECEB9

P304

Q36953151-0F95A0F5-0508-4DE0-BD62-4B79BE9D9D23

P31

Q36953151-4A4CE012-5000-403E-A342-991FD985B5AB

P356

Q36953151-7F9A258C-6CEC-47AC-BBAB-10533A553DAA

P433

Q36953151-084AF63D-75BA-4269-B473-30447418F0FF

P478

Q36953151-FEB8ACC8-6DBB-41D5-B0BE-B8EC4DAD7124

P50

Q36953151-595FB66E-7BD0-40EF-8303-84C33C2E8170

P577

Q36953151-8B005C6A-AFC3-4593-B220-8580FBF7D6F7

P698

Q36953151-EC637AC2-6298-4D30-820D-FC604BF09281

P921

Q36953151-3E6A617D-930B-44D9-89EA-69378A5EA015

Q36953151-86A578E6-4B06-4730-A361-3230FDB652F9

P932

Q36953151-2E77D99D-EFFA-44A0-AF7C-F60644AB651A

P356

P1433

European Heart Journal

P1476

Gene therapy for the treatment of heart failure: promise postponed

@en

P2093

Kiyotake Ishikawa

http://www.w3.org/2001/XMLSchema#string

Roger J Hajjar

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

Epidemiology and risk profile of heart failure

Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

Progress and prospects: immune responses to viral vectors

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Gutless adenovirus: last-generation adenovirus for gene therapy

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

SUMO1-dependent modulation of SERCA2a in heart failure.

Transgenic overexpression of ribonucleotide reductase improves cardiac performance.

P304

1651-1658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHW019

http://www.w3.org/2001/XMLSchema#string

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Sébastien Hulot

P577

2016-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26922809

http://www.w3.org/2001/XMLSchema#string

P921

P932

4887702

http://www.w3.org/2001/XMLSchema#string